REEDOS 50 lamotrigine 50 mg dispersible/chewable tablets bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

lamotrigine, Quantity: 50 mg

Available from:

Strides Pharma Science Pty Ltd

INN (International Name):

Lamotrigine

Pharmaceutical form:

Tablet, dispersible

Composition:

Excipient Ingredients: magnesium stearate; magnesium carbonate hydrate; microcrystalline cellulose; povidone; sucralose; polacrilin potassium; Flavour

Administration route:

Oral

Units in package:

30, 56

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

Lamotrigine is an antiepileptic drug for the treatment of partial and generalised seizures in adults and children.,There is extensive experience with Lamotrigine used initially as ?add-on? therapy. The use of Lamotrigine has also been found to be effective as monotherapy following withdrawal of concomitant antiepileptic drugs.,Initial monotherapy treatment in newly diagnosed paediatric patients is not recommended.

Product summary:

Visual Identification: White to off-white rounded square shaped uncoated tablets debossed with 'H' on multifaceted side and '79' on flat side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Authorization status:

Licence status A

Authorization date:

2012-05-03